Biosino Bio-Technology and Science Incorporation (8247.HK)
HKSE · HKD · Healthcare · Diagnostics & Research
HK$3.01 (-0.50%) as of
Key statistics
- Market cap
- 434.85M
- EPS (TTM)
- -0.320
- Dividend yield
- 0.00%
- 52-week range
- 0.790 – 7.000
- Beta
- 0.52
- Revenue (TTM)
- 170.63M
- Profit margin
- -24.32%
- Volume
- 2.00k
About Biosino Bio-Technology and Science Incorporation
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a strategic cooperation agreement with Xiaoshou Medical Technology Co., Ltd. The company was founded in 1988 and is based in Beijing, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Beijing, China
- Employees
- 386
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.